| Pharmaceutical active ingredients: |
| Dihydroergocristine MesylateEsculosideRutin |
| Available forms, composition and doses of Sandovene F: |
| N / A |
| Sandovene F medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C04AE54 - Dihydroergocristine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sandoz |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Vasoton | Dihydroergocristine Mesylate | NCSN Farmaceutici |
| Vasofluina | Dihydroergocristine Mesylate; Dihydroergotamine Mesylate; Raubasine Hydrochloride | Zambon |
| Defluina | Dihydroergocristine Mesylate; Dihydroergotamine Mesylate; Raubasine; Raubasine Hydrochloride | Ebewe |
| Anavenol | Dihydroergocristine Mesylate; Esculoside; Rutin | Zentiva |
| Sandoven | Dihydroergocristine Mesylate; Esculoside; Rutin | Novartis; Sandoz |
| Ersilan | Dihydroergocristine Mesylate; Etofylline | IVAX |
| Vertizine D | Dihydroergocristine Mesylate; Flunarizine Hydrochloride | Ache Laboratorios Farmaceuticos |
| Diertina Ipotensiva | Dihydroergocristine Mesylate; Hydrochlorothiazide; Reserpine | Poli Industria Chimica |
| Supergan | Dihydroergocristine Mesylate; Hydrochlorothiazide; Reserpine | Sanochemia Pharmazeutika |
| Cervilan | Dihydroergocristine Mesylate; Lomifylline | Sanofi-Aventis |